BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2906956)

  • 21. Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.
    Gordon GD; Mabin TA; Isaacs S; Lloyd EA; Eichler HG; Opie LH
    Am J Cardiol; 1984 May; 53(9):1228-32. PubMed ID: 6143505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
    Cantelli I; Pavesi PC; Naccarella F; Bracchetti D
    Int J Cardiol; 1981; 1(2):151-63. PubMed ID: 7338418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
    Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE
    Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Forsyth D; Taylor SH
    Eur Heart J; 1984 Jan; 5(1):67-79. PubMed ID: 6705807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for combined alpha-beta-adrenoceptor blockade: haemodynamic considerations.
    Koch G
    Acta Med Scand Suppl; 1982; 665():87-92. PubMed ID: 6130680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
    Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
    Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED.
    McDonald AJ; Yealy DM; Jacobson S
    Am J Emerg Med; 1993 Sep; 11(5):460-3. PubMed ID: 8363681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labetalol and nifedipine in the management of essential hypertension.
    Prasad NK
    J Indian Med Assoc; 1990 Jul; 88(7):188-9. PubMed ID: 2266262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.
    Leenen FH; Burns RJ; Myers MG; Frankel D
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):499-504. PubMed ID: 1981020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension--drug management.
    Anand MP
    J Assoc Physicians India; 1982 Feb; 30(2):101-5. PubMed ID: 6132908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.